HER2 Support Group Forums - Synthon’s SYD985 ADC demonstrates anti-tumor activity, outperforms leading anti-HER2

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)

- - Synthon’s SYD985 ADC demonstrates anti-tumor activity, outperforms leading anti-HER2 (https://her2support.org/vbulletin/showthread.php?t=60659)

News	04-02-2014 02:36 AM

Synthon’s SYD985 ADC demonstrates anti-tumor activity, outperforms leading anti-HER2

Synthon Biopharmaceuticals today announced the results of a head-to-head comparative program of its antibody-drug conjugate (ADC) SYD985 with Roche's market leading anti-HER2 ADC, T-DM1 (Kadcyla).

More...

All times are GMT -7. The time now is 01:57 PM.